Parkinson Clinical Trials 2024

Parkinson Clinical Trials 2024

Parkinson research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in parkinson clinical trials today.

Parkinson Clinical Trials

Here are the 6 most popular medical studies for parkinson

Popular filter options for parkinson trials

Parkinson's Disease Clinical Trials

View 96 Parkinson's Disease medical studies.

PD Clinical Trials

View 96 PD medical studies.

Parkinson Clinical Trials With No Placebo

View 96 parkinson medical studies that do not have a placebo group.

View More Parkinson Trials

See another 74 medical studies focused on parkinson.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to parkinson

What are the top hospitals conducting parkinson research?

While clinical trials for [Parkinson's disease]('s-disease) may still be in their early stages, several top hospitals are leading the way in advancing our understanding and treatment of this complex condition. In Toronto, the Toronto Western Hospital is currently conducting six active Parkinson's trials, showcasing its commitment to finding innovative solutions for patients. Moving south to Chicago, Rush University Medical Center has five ongoing trials focused solely on Parkinson's disease. This renowned institution is at the forefront of research and has made significant strides in improving the lives of those affected by this neurodegenerative disorder.

On the West Coast, Stanford University also prioritizes Parkinson's research with four active clinical trials. The expertise and dedication of its medical professionals contribute to groundbreaking advancements that offer hope to individuals living with Parkinson's. Meanwhile, even away from major cities like Chicago or Toronto, specialized centers like the Parkinson's Disease and Movement Disorders Center of Boca Raton are making a difference too. They're actively involved in three ongoing clinical trials dedicated exclusively to exploring new treatments for patients.

Lastly, Northwestern University in Chicago deserves recognition for its contributions as well; it is currently running three active clinical studies focused on treating and managing symptoms associated with Parkinson’s disease while earnestly working towards breakthroughs that could revolutionize how we approach this neurological condition.

These hospitals are not only providing cutting-edge care but also offering opportunities for patients to participate in ground-breaking research studies that have enormous potential implications worldwide- an exciting prospect considering there remain no previously concluded records available within these institutions specifically targeting parkinsonism thus far! Such initiatives pave way forward creating brighter outlooks against Parkinons' fight

Which are the best cities for parkinson clinical trials?

When it comes to clinical trials for [Parkinson's disease]('s-disease), several cities are at the forefront of research and advancement. New york, New York leads the pack with 19 active trials exploring treatments such as BIIB122, ExAblate Pallidotomy, and LY3884961. Philadelphia, Pennsylvania closely follows with 17 ongoing studies focused on ABBV-951, Investigational Treatment 1, and RO7486967 Arm. Additionally, Chicago in Illinois is conducting 14 active trials investigating ABBV-951, BIIB122, and Tavapadon. Lastly Los Angeles in California and Tampa in Florida both have 13 active trials each studying various potential breakthroughs like Movement task and IkT-148009 respectively. These cities offer individuals with Parkinson's disease access to cutting-edge clinical trials that may lead to new treatment options and improved quality of life.

Which are the top treatments for parkinson being explored in clinical trials?

Clinical trials are at the forefront of [Parkinson's disease]('s-disease) research, with several promising treatments currently being explored. One standout option is gene therapy, which aims to correct genetic abnormalities associated with the condition. Another avenue under investigation is deep brain stimulation (DBS), where electrodes are implanted in specific regions of the brain to alleviate symptoms. Additionally, researchers are looking into novel medications that target specific pathways involved in Parkinson's progression, providing hope for improved treatment options in the future.

What are the most recent clinical trials for parkinson?

Exciting advancements in [Parkinson's disease]('s-disease) research are underway through recent clinical trials. One promising trial is evaluating the effectiveness of Waitlist Couple Pairs Parkinson's Group, a Phase 2 study that aims to improve outcomes for patients with Parkinson's. Another Phase 2 trial focuses on IkT-148009 and its potential benefits in managing the symptoms of this neurodegenerative disorder. In addition, Terazosin therapy is being investigated in a Phase 2 trial to assess its efficacy as a treatment option. These studies offer hope for improved quality of life and better management strategies for individuals living with Parkinson's disease.

What parkinson clinical trials were recently completed?

Several recent clinical trials have made significant advancements in the field of [Parkinson's disease]('s-disease) research. Notably, a trial sponsored by AbbVie completed in September 2021 focused on evaluating the efficacy of ABBV-951, a potential treatment option for this neurodegenerative disorder. Additionally, Biogen concluded their study on BIIB054, another promising therapy for Parkinson's disease, in June 2021. These important milestones highlight the ongoing efforts to discover innovative treatments that could potentially improve the lives of individuals living with Parkinson's disease.